Logo

(651) 644-8424

(888) 558-5227

(651) 644-8357
 
  
Welcome!    Login or Register
0 item(s)
PRODUCT
New Products
Antimicrobials
Apoptosis
Biologically Active Peptides
Cancer
Cancer Chemopreventives
Cardiovascular
Drug Discovery Kits
Inflammation
Natural Products
Neurobiology
Signal Transduction
Toxins
Alphabetical List

Ramatroban
Ramatroban
Click over image to enlarge
Product No Price Quantity Subtotal
R0248-10mg $147.80
R0248-25mg $320.30
R0248-100mg $1,047.20
Total 
 
Description
A thromboxane receptor antagonist, a CRTH2 antagonist. It is indicated for the treatment of coronary artery disease. It has also been used for the treatment of asthma.
Specifications
Cas No.
116649-85-5
Product ID
R0248
Product Name
Ramatroban
Formula Wt.
416.47
Store Temp
Ambient
References
Sugimoto H, Shichijo M, Iino T, et al. (April 2003). "An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro". J. Pharmacol. Exp. Ther. 305 (1): 347–52. Royer JF, Schratl P, Carrillo JJ, et al. (September 2008). "A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils". Eur. J. Clin. Invest. 38 (9): 663–71. Fiedler VB, Seuter F, Perzborn E (December 1990). "Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease". Stroke 21 (12 Suppl): IV149–51. PMID 2260140. Endo S, Akiyama K (November 1996). "[Thromboxane A2 receptor antagonist in asthma therapy]" (in Japanese). Nippon Rinsho 54 (11): 3045–8. PMID 8950952.